Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin vs Pravastatin in Hyperlipidemia with Diabetes or Metabolic Syndrome
NCT00166036Phase 2Completed
- Sponsor
- Emory University
- Start
- Sep 2004
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of atorvastatin in hypercholesterolemia, diabetes mellitus (DM) and metabolic syndrome (2 arms), sponsored by Emory University. Primary endpoint: Plasma Thiobarbituric Acid Reactive Substance Levels at 12 weeks. Started Sep 2004; status: completed.
02
Drugs
atorvastatin
03
Conditions
hypercholesterolemiadiabetes mellitus (DM)metabolic syndrome
Beyond the preview
Go deeper on NCT00166036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00166036.